20 May 2013
Keywords: astrazeneca, wins, fast-track, review, usa, new, arimidex
Article | 22 April 2002
The US Food and Drug Administration has granted a six-month priorityreview to AstraZeneca's supplemental New Drug Application for the use ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 April 2002
© 2013 thepharmaletter.com